Normal healthy pregnancy is a state in which physiological stresses that are capable of inducing protein misfolding are considerably heightened. In part, these stresses are the consequence of a systemic inflammatory response involving the generation of reactive oxygen species ([@r1]), which contribute to a measurable increase in the oxidation of maternal plasma proteins ([@r2]). The placenta, which is the interface between the mother and the developing fetus, is another major contributor to the generation of reactive oxygen species, due to its high level of metabolic activity (reviewed in ref. [@r3]). Additionally, body temperature is slightly, but chronically, elevated during pregnancy ([@r4]), and a tremendous increase in blood volume promotes shear stress ([@r5], [@r6]). As pregnancy advances, the fetoplacental unit produces many new secreted proteins that all need to be trafficked and ultimately cleared by maternal organs under these physically unfavorable conditions. Remarkably, virtually nothing is known regarding the way that the maternal body adapts to handle the unique protein homeostasis (proteostasis) challenges of pregnancy.

Aberrant accumulation of misfolded proteins in extracellular fluids underlies the pathology of a large number of age-related disorders, including Alzheimer's disease, macular degeneration, arthritis, and atherosclerosis ([@r7]). Aside from these age-related disorders, misfolded proteins have been shown to accumulate in the urine, serum, and the placenta of women with preeclampsia ([@r8][@r9][@r10][@r11]--[@r12]), a leading cause of pregnancy-related morbidity and mortality. The broad spectrum of disorders known to involve protein misfolding highlights the fact that proteins are vulnerable to misfolding as a consequence of genetic and environmental changes ([@r13]), including pressures that occur as a normal part of pregnancy in mammals. A collapse in the proteostasis network is recognized as a key event associated with aging and ultimately death ([@r14]). Intuitively, to cope with pregnancy-associated physiological stresses, the functions of the pregnancy-associated proteostasis network will be critically important.

A small number of normally secreted proteins including clusterin, haptoglobin, and alpha-2-macroglobulin (α~2~M) have been shown to stabilize and inhibit the aggregation of misfolded proteins (reviewed in ref. [@r15]). Collectively, these proteins are known as extracellular chaperones. Levels of known extracellular chaperones do not increase significantly in maternal blood during normal healthy pregnancy ([@r16][@r17][@r18]--[@r19]). Therefore, it is conceivable that one or more pregnancy-associated proteins, which are up-regulated during gestation, play a major role in stabilizing misfolded proteins. Of the numerous changes that occur in the maternal plasma proteome during pregnancy, one of the most dramatic is the increase in pregnancy zone protein (PZP) levels. The concentration of PZP in human blood plasma is normally \<0.03 mg/mL, but by 30 wk of gestation PZP levels can reach up to 1.5 to 3 mg/mL in some individuals ([@r20]). It is currently unclear why the body makes this tremendous investment in the up-regulation of PZP in pregnancy when levels of α~2~M, a closely related α-macroglobulin (αM) family member, are constitutively high in human blood plasma \[∼1.5 to 2 mg/mL ([@r21])\].

In humans, α~2~M (a tetramer) and PZP (a dimer) share 71% sequence homology ([@r22]), and are historically best known as protease inhibitors. However, compared with α~2~M, PZP is relatively inefficient at performing this activity, and PZP--protease interactions have only been described for a restricted number of protease substrates in vitro ([@r23][@r24][@r25][@r26]--[@r27]). In more recent years, the multifunctional nature of α~2~M has become apparent (reviewed in ref. [@r28]). For example, reaction of α~2~M with hypochlorite, an oxidant that is produced during inflammation, induces the dissociation of the native α~2~M tetramer into dimers ([@r29], [@r30]). The hypochlorite-induced dissociation of α~2~M into dimers results in a loss of the protease-trapping activity of α~2~M ([@r30]) but a potent activation of its chaperone activity ([@r29]). Compared with the native α~2~M tetramer, α~2~M dimers preferentially bind not only to misfolded proteins but also to a variety of other ligands, including signaling molecules ([@r29], [@r31], [@r32]). Given that PZP is normally a dimer in biological fluids, we hypothesized that PZP could be an efficient chaperone that stabilizes misfolded proteins in a manner similar to dimeric α~2~M. In the present study, we examined the effect of purified PZP on the fibrillar aggregation of the Aβ peptide associated with Alzheimer's disease, which has also been implicated in pathological changes occurring in the placenta in preeclampsia ([@r8]). To increase the physiological relevance of our studies, we investigated the aggregation propensity of proteins in pregnancy plasma in situ and determined the localization of PZP in placental tissue from women with preeclampsia and of control women matched by gestational age.

Results {#s1}
=======

Pregnant Women with Low PZP Levels Do Not Compensate by Up-Regulating α~2~M. {#s2}
----------------------------------------------------------------------------

PZP was purified from pooled human pregnancy plasma as described previously ([@r33]). When analyzed by native Western blotting, purified PZP migrated to the same position as PZP in heparin-treated human pregnancy plasma ([Fig. 1*A*](#fig01){ref-type="fig"}). This was important to assess, because purified PZP has a tendency to aggregate during extended storage, a process that has functional consequences ([@r34]). The polyclonal anti-PZP antibody used in these experiments did not react with highly purified α~2~M, verifying its specificity for PZP ([Fig. 1*A*](#fig01){ref-type="fig"}). By native gel analysis, the migration of purified PZP was faster than that of native and transformed α~2~M (α~2~M\*; a compact tetrameric form generated by reaction of the α~2~M thioester bond) but comparable to that of hypochlorite-liberated α~2~M dimers ([Fig. 1*B*](#fig01){ref-type="fig"}). The latter migrated in a more diffuse manner compared with PZP, consistent with a heterogeneous population of species differing slightly in physical properties that are present in the hypochlorite-modified α~2~M preparation ([@r29]). The results of native Western blot analyses indicated that there was marked variation in plasma levels of PZP between individuals matched for gestational age (36 wk), while plasma levels of α~2~M were comparatively similar in all of the samples examined ([Fig. 1*C*](#fig01){ref-type="fig"}). Densitometric analysis of α~2~M and PZP (collectively referred to as αMs) in pregnancy plasma indicated that there is only a weak correlation between PZP and α~2~M levels (*R*^2^ = 0.2236) ([Fig. 1*D*](#fig01){ref-type="fig"}). The latter result supports the conclusion that individuals with low PZP in pregnancy do not compensate by up-regulating α~2~M.

![Western blot and native PAGE analyses of PZP in human pregnancy plasma and following purification. (*A*) Image of a Western blot showing the migration of PZP pre- and postpurification from pregnancy plasma, after separation using a 3 to 8% Tris-acetate native gel. The position of PZP is indicated with an arrow. A corresponding amount of purified α~2~M was not detected (final lane). (*B*) Image of a 3 to 8% Tris-acetate native gel showing the migration of purified PZP, α~2~M, transformed α~2~M (an electrophoretically fast tetramer), and hypochlorite-modified α~2~M (α~2~M ox). The positions of αM tetramers and dimers are indicated. (*C*) Images of Western blots showing the relative PZP levels in eight individual pregnant women at 36 wk gestation. Pregnancy plasma (1 µL) was separated using a 3 to 8% Tris-acetate native gel, and proteins were transferred to a nitrocellulose membrane. The blot was initially probed using an anti-PZP antibody, and then the same blot was reprobed using an anti-α~2~M antibody. Images show the major bands detected, and are cropped and realigned to assist comparison of the respective levels of PZP and α~2~M present. (*D*) Densitometry analysis of Western blots showing the relative levels of PZP and α~2~M in 14 individual women at 36 wk of pregnancy. *R*^2^ is calculated using Pearson's correlation coefficient.](pnas.1817298116fig01){#fig01}

PZP Inhibits Aβ~1--42~ Amyloid Formation More Efficiently than Native α~2~M. {#s3}
----------------------------------------------------------------------------

The ability of purified PZP to inhibit the fibrillar aggregation of the 42-residue isoform of the Aβ peptide (Aβ~1--42~) was assessed using the well-established thioflavin T (ThT) assay. Under the conditions used, Aβ~1--42~ aggregated over a period of ∼10 h following a short lag phase of ∼1 h ([Fig. 2*A*](#fig02){ref-type="fig"}). Coincubation of Aβ~1--42~ with PZP both extended the lag phase and reduced the rate of fibril formation in a dose-dependent manner ([Fig. 2*A*](#fig02){ref-type="fig"}). Compared with the native α~2~M tetramer, PZP more efficiently inhibited the ThT fluorescence associated with the formation of amyloid fibrils of Aβ~1--42~, except at the lowest ratio of αM to Aβ~1--42~ tested (i.e., 1 molecule of α~2~M or PZP to 80 molecules of Aβ~1--42~) ([Fig. 2*A*](#fig02){ref-type="fig"}). In the latter case, both native α~2~M and PZP reduced the initial rate of fibril formation but did not significantly reduce the overall ThT fluorescence at the conclusion of the assay. Consistent with our previous report ([@r29]), α~2~M dimers (generated by pretreatment with hypochlorite and purified by size-exclusion chromatography) inhibited Aβ~1--42~--associated ThT fluorescence far more efficiently than the native α~2~M tetramer in all experiments ([Fig. 2*A*](#fig02){ref-type="fig"}). Comparatively, the effect of PZP was less than that of the hypochlorite-modified α~2~M dimer preparation, except at the highest ratio of αM to Aβ~1--42~ tested (i.e., 1 molecule of PZP or α~2~M dimer to 20 molecules of Aβ~1--42~), when the two dimeric proteins had similar effects. The results of a bisANS (4,4-dianilino-1,1-binaphthyl-5,5-disulfonic acid) assay suggest that surface-exposed hydrophobicity underpins the chaperone activity of αMs ([Fig. 2*B*](#fig02){ref-type="fig"}). Consistent with the results of prior studies ([@r35], [@r36]), our data show that native PZP is relatively more hydrophobic than native α~2~M. In the case of the hypochlorite-modified α~2~M dimer, the dramatically elevated surface hydrophobicity is the combined effect of the dissociation of the normally buried hydrophobic interface of noncovalently associated α~2~M dimers and of hypochlorite-induced perturbations to the secondary structure of α~2~M ([@r29]). Considering that tetrameric α~2~M (720 kDa) and PZP (360 kDa) are both composed of monomeric αM subunits (180 kDa), comparison of native α~2~M and PZP at equivalent molar ratios (as in [Fig. 2*A*](#fig02){ref-type="fig"}) is biased in terms of total αM subunit number (and mass) in favor of α~2~M. Therefore, we reevaluated the ability of native α~2~M and PZP to inhibit Aβ~1--42~--associated ThT fluorescence under conditions where the total numbers of αM subunits were equivalent ([Fig. 2*C*](#fig02){ref-type="fig"}). The latter experiment demonstrates that on a subunit basis, the ability of native PZP to inhibit Aβ~1--42~--associated ThT fluorescence is substantially greater than that of native α~2~M in vitro.

![Effects of the α~2~M tetramer, α~2~M dimer, and PZP on the aggregation of Aβ~1--42~ as assessed by ThT assay. (*A*) Aβ~1--42~ (5 µM) was incubated with 25 µM ThT in PBS at 32 °C with constant shaking. Aβ~1--42~ was also coincubated with either native α~2~M, PZP, or SEC-purified α~2~M dimer at molar ratios of (*i*) 1:80, (*ii*) 1:40, or (*iii*) 1:20 (αM to Aβ~1--42~) under the same conditions. The results shown are the average ThT fluorescence (excitation, 440 nm; emission, 480 nm; *n* = 4 ± SEM) in arbitrary fluorescence units (AFUs), and are representative of three independent experiments. The symbol \* denotes significantly reduced ThT fluorescence compared with Aβ~1--42~ alone and corresponding samples coincubated with native α~2~M as assessed at the end of the assay \[Tukey honest significant difference (HSD), *P* \< 0.05\], and \*\* denotes significantly reduced ThT fluorescence compared with Aβ~1--42~ alone as assessed at the end of the assay (Tukey HSD, *P* \< 0.05). (*B*) Corresponding bisANS analysis of αM preparations as described in *A*. The data are the mean bisANS fluorescence (excitation, 360 ± 10 nm; emission, 490 ± 10 nm) of triplicate samples ±SEM and are corrected for background fluorescence. \* denotes significantly higher bisANS fluorescence of PZP compared with native α~2~M (Tukey HSD, *P* \< 0.01), and \*\* denotes significantly higher bisANS fluorescence of dimeric α~2~M compared with native α~2~M and PZP (Tukey HSD, *P* \< 0.01). (*C*) The effects of native α~2~M and PZP on amyloid formation were examined using an αM subunit-to-Aβ~1--42~ ratio of 1:20; under these conditions the masses of α~2~M and PZP used in the assay are equivalent. The results shown are the average ThT fluorescence (AFUs) of triplicate samples and are representative of three independent experiments. Error bars are the SEM. The symbol \* denotes significantly reduced ThT fluorescence compared with Aβ~1--42~ alone and corresponding samples coincubated with native α~2~M as assessed at the end of the assay (Tukey HSD, *P* \< 0.05).](pnas.1817298116fig02){#fig02}

Qualitative analysis by transmission electron microscopy (TEM) indicated that aggregation of Aβ~1--42~ alone resulted in assemblies with morphologies consistent with amyloid fibrils ([Fig. 3*A*](#fig03){ref-type="fig"}). The relative abundance of fibrillar material observed correlated closely with the results of the ThT assays whereby coincubation with the native α~2~M tetramer appeared less efficient at inhibiting fibril formation compared with PZP and the hypochlorite-modified α~2~M dimer, respectively ([Fig. 3*A*](#fig03){ref-type="fig"}). In samples containing Aβ~1--42~ and PZP, small nonfibrillar aggregates that were relatively uniform in size and morphology were present. Interestingly, quantification of the concentration of soluble Aβ~1--42~ at the conclusion of the assay indicated that under the conditions used, coincubation with PZP or hypochlorite-modified α~2~M dimers retained a similar amount of Aβ~1--42~ in the soluble fraction ([Fig. 3*B*](#fig03){ref-type="fig"}). Corresponding samples containing Aβ~1--42~ coincubated with native α~2~M, however, contained less than 10% of the levels of soluble Aβ~1--42~ present after coincubation with dimeric αMs ([Fig. 3*B*](#fig03){ref-type="fig"}). Following incubation of Aβ~1--42~ in the absence of any of the proteins at 37 °C, soluble Aβ~1--42~ could not be detected.

![TEM images of Aβ~1--42~ after coincubation with α~2~M tetramer, α~2~M dimer, or PZP, and corresponding measurements of soluble Aβ~1--42~. (*A*) Aβ~1--42~ (5 µM) was incubated ± native α~2~M, PZP, or SEC-purified α~2~M dimer at a molar ratio of 1:20 (αM to Aβ~1--42~) at 32 °C with constant shaking for ∼15 h. Samples of the protein solutions were snap-frozen in liquid nitrogen before analysis by TEM. (Scale bars, 100 nm.) (*B*) After incubation as described in *A*, insoluble Aβ~1--42~ was removed by centrifugation (21,000 × *g*) and soluble Aβ~1--42~ was quantified by densitometry following Western blot analysis (*n* = 3 ± SEM). The density of soluble Aβ~1--42~ in samples containing dimeric αMs (gray) is presented relative to soluble Aβ~1--42~ in samples containing native tetrameric α~2~M (black). N.D., not detected; N.S., not significantly different (Tukey honest significant difference; *P* \> 0.05).](pnas.1817298116fig03){#fig03}

PZP Forms Stable Complexes with Aβ~1--42~. {#s4}
------------------------------------------

We have previously reported that monomeric Aβ~1--42~ and/or small soluble species formed early in the aggregation pathway bind to hypochlorite-modified α~2~M but do not bind to the native α~2~M tetramer in vitro ([@r29]). Consistent with this report, when Hilyte-labeled Aβ~1--42~ was coincubated with native α~2~M and then subjected to native gel electrophoresis, negligible comigration of labeled Aβ~1--42~ with the α~2~M tetramer was detected ([Fig. 4*A*](#fig04){ref-type="fig"}). In contrast, when Hilyte-labeled Aβ~1--42~ was coincubated with either hypochlorite-modified α~2~M or PZP, significant levels of labeled Aβ~1--42~ comigrating with these proteins during native gel electrophoresis were detected in both cases ([Fig. 4*A*](#fig04){ref-type="fig"}). The formation of stable PZP--Aβ~1--42~ complexes was confirmed using a streptavidin--biotin pull-down assay, and demonstrated that PZP (180 kDa) coeluted with biotinylated Aβ~1--42~ at much greater levels than was the case for the nonspecific binding of PZP to the streptavidin beads alone ([Fig. 4*B*](#fig04){ref-type="fig"}). Although monomeric Aβ~1--42~ could not be detected comigrating with the native α~2~M tetramer ([Fig. 4*A*](#fig04){ref-type="fig"}), when analyzed by native Western blotting, comigration of Aβ~1--42~ and the native α~2~M tetramer was detected if the peptide was preincubated to induce its aggregation ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental)).

![αM--Aβ~1--42~ complexes detected by native PAGE and biotin--streptavidin pull-down assay. (*A*, *i*) Fluorescence image of a native gel showing the migration of Hilyte Fluor 488-labeled Aβ~1--42~ after incubation alone or with αMs at a 1:10 molar ratio of αM:Aβ~1--42~. α~2~M ox and α~2~M ox2 denote α~2~M pretreated with 25 and 100 µM NaOCl, respectively, followed by dialysis to remove unreacted NaOCl. All samples were incubated for 30 min at ambient room temperature. (*A*, *ii*) Following fluorescence imaging, the gel was stained with Instant Blue and reimaged to determine the position of all proteins. (*B*) Image of a Western blot detecting PZP recovered by biotin--streptavidin pull-down assay after incubation in the presence (+) or absence (−) of biotinylated Aβ~1--42~ for 30 min at room temperature. Samples were incubated at a molar ratio of PZP:Aβ~1--42~ 1:10 and were subjected to denaturing gel electrophoresis under reducing conditions before Western blot analysis. Under these conditions, the PZP dimer migrates as a 180-kDa monomer. The positions of molecular-mass markers (Mr) are shown in kDa.](pnas.1817298116fig04){#fig04}

PZP Inhibits Heat-Induced Protein Aggregation. {#s5}
----------------------------------------------

Considering that the accumulation of misfolded proteins in preeclampsia is not limited to the Aβ peptide ([@r8][@r9][@r10][@r11]--[@r12]), we examined the effect of PZP on the heat-induced aggregation of citrate synthase (CS), a model protein used to form amorphous protein aggregates. Heating of CS at 43 °C induced its aggregation over a period of ∼5 h as measured by the absorbance of the solution at 595 nm (i.e., turbidity), and coincubation of CS with PZP reduced the level of CS aggregation in a dose-dependent manner ([Fig. 5*A*](#fig05){ref-type="fig"}). At a 1:2.5 molar ratio (PZP to CS), the inhibitory effect of PZP on the aggregation of CS was significantly greater than the comparable effect of native α~2~M at the conclusion of the assay ([Fig. 5*A*](#fig05){ref-type="fig"}). For clarity, kinetic curves ([Fig. 5 *A*](#fig05){ref-type="fig"}, *i*) and statistical analysis of end-point absorbance values ([Fig. 5 *A*](#fig05){ref-type="fig"}, *ii*) are presented separately. To examine the possibility that monomeric αMs also stabilize misfolded proteins in vitro, the chaperone activities of native α~2~M, PZP, and monomeric *Escherichia coli* α~2~M (ECAM) were directly compared using heat-denatured creatine phosphokinase (CPK; another commonly used model protein that forms amorphous aggregates). The results of these assays indicate that, like tetrameric α~2~M, monomeric ECAM is relatively ineffective in suppressing heat-induced CPK aggregation compared with PZP ([Fig. 5*B*](#fig05){ref-type="fig"}). We have previously shown that hypochlorite-modified α~2~M dimers more efficiently inhibit amorphous protein aggregation compared with the native α~2~M tetramer ([@r29]); the available evidence therefore supports the conclusion that dimeric quaternary structure is important for the chaperone activity of the αMs. To verify that purified ECAM did not aberrantly form higher-order assemblies such as dimers or tetramers, a native gel showing the migration of purified ECAM compared with reduced monomeric α~2~M is provided in [*SI Appendix*, Fig. S2](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental).

![Effect of αMs on the heat-induced aggregation of CS. (*A*) CS at 1 μM was incubated at 43 °C ± PZP or α~2~M. The molar ratios of αM:CS used are shown. Turbidity was monitored using absorbance at 595 nm. The data shown in *i* are the mean of triplicate samples and are representative of two independent experiments. For clarity, the mean absorbance at 595 nm (A595 nm) at the end point of the assay including error bars is provided in *ii* (*n* = 3 ± SEM). The symbol \* denotes significantly reduced turbidity compared with the control sample containing CS alone (black bar) \[Tukey honest significant difference (HSD), *P* \< 0.05\], and \*\* denotes significantly reduced turbidity compared with the sample containing CS alone and the sample containing a corresponding amount of α~2~M (shaded area) (Tukey HSD, *P* \< 0.05). (*B*) Turbidity assay showing CPK (5 μM) incubated at 55 °C in PBS ± ECAM, PZP, or α~2~M. The molar ratio of αM:CPK was 1:5. Turbidity was monitored using absorbance at 595 nm. The data shown are individual measurements and are representative of two independent experiments. (*C*) Pooled plasma from individuals exhibiting normal uncomplicated pregnancy (control) or preeclampsia ([Table 1](#t01){ref-type="table"}) was incubated at 38 °C for 500 h and routinely agitated. The turbidity was assessed using A595 nm. A bar chart displaying the mean A595 nm is shown (*n* = 4 ± SEM) and is representative of two independent experiments. The symbol ^†^ denotes significantly increased A595 nm at 500 h compared with 0 h (Student's *t* test, *P* \< 0.05).](pnas.1817298116fig05){#fig05}

Using conditions that are known to induce plasma protein precipitation ([@r37], [@r38]), the aggregation propensities of plasma proteins from preeclamptic women or women experiencing uncomplicated pregnancy (control) were examined in situ. The two types of pooled plasma samples examined were similar in terms of their total protein levels and maternal ages, but the pooled preeclampsia plasma sample contained ∼50% less PZP than the control, and the mean gestational ages of the two cohorts differed by several weeks ([Table 1](#t01){ref-type="table"}). The data show that after 500 h of incubation, the turbidity of the PZP-deficient pooled plasma sample from preeclamptic women had increased significantly, but no significant change was detected in the pooled sample from matched controls ([Fig. 5*C*](#fig05){ref-type="fig"}). Combined together, these results support the conclusion that similar to other extracellular chaperones ([@r15]), PZP stabilizes a range of misfolded protein clients, including aggregation-prone peptides and denatured proteins.

###### 

Characteristics of plasma samples that were pooled from individuals exhibiting preeclampsia or uncomplicated pregnancy (control)

  Characteristic                                        Preeclampsia   Control
  ----------------------------------------------------- -------------- --------------
  Total protein, mg/mL                                  59 ± 1         60 ± 1
  PZP[\*](#tfn1){ref-type="table-fn"}, mg/mL            0.22 ± 0.004   0.46 ± 0.011
  Maternal age, y                                       33 ± 6.0       34 ± 3.9
  Gestational age[\*](#tfn1){ref-type="table-fn"}, wk   33 ± 2.7       28 ± 1.5
  Individual samples pooled, *n*                        9              6

Significant difference between the two cohorts (Student's *t* test, *P* \< 0.05).

Endogenous Proteases Do Not Induce the Formation of Tetrameric PZP in Blood Plasma in Situ. {#s6}
-------------------------------------------------------------------------------------------

As previously mentioned, demonstration of the protease-trapping action of PZP has currently been limited to studies involving purified protein in vitro ([@r23][@r24][@r25][@r26]--[@r27]). In the present study, to evaluate the protease-trapping action of purified PZP versus PZP in plasma, the effects of incubation with chymotrypsin were determined. When purified PZP was coincubated with chymotrypsin (molecular mass 25 kDa), a small amount of PZP was found to form a high-molecular-mass species ([Fig. 6*A*](#fig06){ref-type="fig"}). This result supports a proposed model for protease trapping in which two PZP molecules form a tetrameric complex around the covalently bound protease ([@r23]). Interestingly, when human pregnancy plasma was incubated at 37 °C for 45 min and assessed by native Western blot analysis, there was negligible evidence that a similar high-molecular-mass PZP species is formed under these conditions in situ ([Fig. 6 *B*](#fig06){ref-type="fig"}, *i*). Moreover, supplementation of the plasma with 1 µM chymotrypsin had no observable effect on the migration of PZP. In the same plasma samples, native α~2~M was converted to an electrophoretically fast form (similar to α~2~M\*; [Fig. 1*B*](#fig01){ref-type="fig"}), and the effect was greater when the plasma was supplemented with chymotrypsin ([Fig. 6 *B*](#fig06){ref-type="fig"}, *ii*). The latter behavior is consistent with protease trapping by α~2~M, which causes the α~2~M tetramer to become compact ([@r24]). In contrast to the anti-α~2~M antibody that was found to bind strongly to protease-bound electrophoretically fast α~2~M ([Fig. 6 *B*](#fig06){ref-type="fig"}, *ii*), the anti-PZP polyclonal antibody used in this study bound preferentially to the native PZP dimer ([*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental)). Given that the putative PZP--protease complexes were not detected in situ following the addition of high levels of chymotrypsin ([Fig. 6*B*](#fig06){ref-type="fig"}), densitometry was used to confirm that the levels of native PZP in plasma were not detectably reduced following the addition of chymotrypsin ([Fig. 6*C*](#fig06){ref-type="fig"}).

![αM--protease complex formation in vitro and in situ. (*A*) Image of a native gel showing the migration of purified native PZP and PZP--protease complexes. Putative PZP--protease complexes were generated by preincubation with chymotrypsin (chym) at a 2:1 molar ratio of PZP to chym for 30 min at 37 °C. (*B*) Native Western blot analysis showing putative αM--protease complexes in human pregnancy plasma. Heparinized human pregnancy plasma was incubated at 37 °C for 45 min in the presence or absence of 1 µM chym. An additional sample was held at 4 °C on ice for the same period (control). Blots probed for (*i*) PZP or (*ii*) α~2~M are from the same experiment. The expected positions of the PZP--chym and α~2~M--chym complexes are indicated. (*C*) The band corresponding to the native PZP dimer was quantified using densitometry in pregnancy plasma treated as described in *B*. The graph shows the mean PZP level relative to the control (*n* = 5 independent experiments ± SD).](pnas.1817298116fig06){#fig06}

PZP Is Predominantly Absent from Extracellular Aβ Deposits in Preeclampsia. {#s7}
---------------------------------------------------------------------------

We have previously reported the presence of amyloid precursor protein proteoforms in amyloid-like plaques in placentas from women with severe preeclampsia comorbid with fetal growth restriction ([@r8]). To identify if there is potential for PZP to act as a local chaperone in the placenta, we performed immunohistochemical analysis of well-characterized cases of preterm birth with and without preeclampsia and/or fetal growth restriction; relevant clinical information pertaining to these samples is provided in [*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental). Extravillous trophoblasts (EVTs) in the basal plate, placental septa, and cell islands stained strongly for PZP in all clinical scenarios, but several patterns emerged relative to histological changes in placenta that are commonly associated with preeclampsia ([Fig. 7 *A*--*C*](#fig07){ref-type="fig"}). In the maternal floor of the placenta of idiopathic preterm birth, PZP-positive EVTs were seen scattered ([Fig. 7*A*](#fig07){ref-type="fig"}); in preeclampsia, however, they appeared to migrate around avascular villi ([Fig. 7 *B* and *C*](#fig07){ref-type="fig"}), thus contributing to the characteristic "lacy appearance" of confluent placental islands ([Fig. 7*D*](#fig07){ref-type="fig"}) classically described in preeclamptic placentas populated by increased numbers of proliferating migratory EVTs ([@r39], [@r40]). Staining of serial sections supported the notion that these cells also harbor Aβ ([Fig. 7*E*](#fig07){ref-type="fig"}) as well as cytokeratin-7 ([Fig. 7*F*](#fig07){ref-type="fig"}), thus confirming their trophoblast phenotype.

![Immunolocalization of PZP in the human preterm placenta. (*A*--*C*) Representative micrographs of the maternal floor of the placenta at the interface between the basal plate (*bp*) and villous tissue (*vt*) in (*A*) iPTB, idiopathic preterm birth (gestational age-matched control); (*B*) sPE, severe preeclampsia; and (*C*) sPE+FGR, fetal growth restriction. (*D*--*F*) Serial sections of placenta from a woman with early-onset sPE+FGR showing a confluent placental cell island (*cpci*) at the interface between villous tissue and the chorionic plate (*cp*). The sections have been immunostained for (*D*) PZP, (*E*) Aβ, and (*F*) cytokeratin-7 (CK7). (*G*) Negative control slide exposed to nonimmune rabbit IgG. Vector Red was used as peroxidase substrate and hematoxylin as counterstain. The *Insets* show at higher magnification regions populated by extravillous trophoblasts which are arranged in an orderly manner in iPTB but border many avascular ghost villi in preeclampsia (black arrows). (Scale bars, 100 µm.) (*H*--*J*) Confocal microscopy of placenta from two women with sPE+FGR double-immunostained for PZP (red fluorescence) and Aβ (green fluorescence). DAPI was used as nuclear counterstain. (*H*) A confluent placental cell island populated by PZP-positive extravillous trophoblasts and plaque-like deposits of extracellular Aβ (orange arrows); dead or dying cells in the vicinity of Aβ deposits (white arrows); trophoblasts staining positive for PZP surround many avascular ghost villi (white asterisks). Higher magnification of the area in *H* framed in continuous line (*I*) with additional magnification and z-stack 3D reconstruction of the area framed in *H* (*J*). The irregular cellular shape and loss of nuclear DAPI staining suggest cell death. The blue arrows point to intensely yellow fluorescence generated by proximity of PZP and Aβ epitopes. (Scale bars, 50 µm.)](pnas.1817298116fig07){#fig07}

To determine whether or not PZP colocalizes with Aβ in insoluble plaques in vivo, we performed double-immunofluorescence studies with a particular focus on confluent placental islands ([Fig. 7 *H*--*J*](#fig07){ref-type="fig"}). EVTs that were stained intensely red for PZP were seen surrounding acellular areas in the vicinity of extracellular green fluorescent Aβ deposits (orange arrows, [Fig. 7*H*](#fig07){ref-type="fig"}) and isolated EVTs, which appeared morphologically necrotic (white arrows). The vicinity between extracellular Aβ and dying EVTs was better appreciated using confocal imaging ([Fig. 7*I*](#fig07){ref-type="fig"}). Upon z-stack reconstruction, zones of merged yellow fluorescence suggested that a small amount of PZP was codeposited with Aβ in plaques ([Fig. 7*J*](#fig07){ref-type="fig"}, blue arrows), although it is clear that deposited Aβ is not predominantly bound to PZP. Further analysis of the intracellular location of PZP and Aβ is presented in [*SI Appendix*, Fig. S4](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental).

Discussion {#s8}
==========

Consistent with the functions of PZP having systemic importance throughout pregnancy, PZP levels are dramatically elevated in blood plasma from an early stage during gestation ([@r20]). The latter is a relevant observation, as the accumulation of misfolded proteins is not isolated to the placenta in preeclampsia but has been measured in serum and urine ([@r8], [@r9], [@r12]). The results of this study demonstrate that PZP stabilizes Aβ and other misfolded client proteins more efficiently than the constitutively abundant α~2~M tetramer, which has received substantial attention for its role as an extracellular chaperone (reviewed in ref. [@r15]). Given the extent to which PZP is up-regulated in mid to late pregnancy, it is conceivable that PZP is a major regulator of extracellular proteostasis during gestation. However, it is probable that PZP does not act alone to stabilize misfolded proteins in maternal fluids \[e.g., modest chaperone-like activity has been reported for the pregnancy-associated SERPINB2 ([@r41])\]. Thus, the results generated from the current study provide an important first step toward understanding how the maternal body adapts to handle the unique challenges to extracellular proteostasis during pregnancy.

A Model for the Related Chaperone Mechanisms of PZP and α~2~M. {#s9}
--------------------------------------------------------------

Our data show that native PZP (a dimer) exposes greater hydrophobic surface area to solution than native tetrameric α~2~M, and binds to Aβ monomers and/or small Aβ oligomers that do not form stable complexes with native α~2~M. Therefore, the results of this study support a model in which binding sites for Aβ (and other misfolded proteins) are present on constitutively exposed hydrophobic surfaces of the native PZP dimer that, in the closely related native α~2~M tetramer, are located at the normally buried hydrophobic interface between pairs of disulfide-linked α~2~M dimers ([@r42], [@r43]). Consistent with this model, we have previously shown that hypochlorite-induced dissociation of the native α~2~M tetramer enhances its binding to Aβ ([@r29]). Although the precise binding sites for Aβ on PZP are not yet known, a previously reported binding site for Aβ on α~2~M (centered at amino acids 1314 to 1365, but sterically shielded in the native α~2~M tetramer [@r44]) shares 85.7% sequence identity with the corresponding region of PZP ([*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental)).

The available data suggest that native α~2~M can be rapidly induced to become PZP-like via hypochlorite-induced dissociation ([@r29]), which potentially acts as an important first line of defense that transiently increases αM-mediated chaperone activity during severe inflammation. Considering that elevated myeloperoxidase levels have been reported in preeclampsia ([@r45]), it is plausible that hypochlorite-modified α~2~M is transiently generated during an advanced stage of the syndrome that corresponds to severe inflammatory processes. Further studies to identify the precise conformations of hypochlorite-modified α~2~M that are generated during inflammation and to define their relative abundance are needed to appreciate fully the importance of this process in vivo. Given the highly multifunctional nature of α~2~M, the current study paves the way for evaluating whether or not other activities that are enhanced by dissociation of the native α~2~M tetramer, such as binding to cytokines ([@r32]), are also important roles for PZP.

The Chaperone Activity of PZP Potentially Influences Pregnancy-Associated and Pregnancy-Independent Protein Misfolding. {#s10}
-----------------------------------------------------------------------------------------------------------------------

Interest in the role of α~2~M in Alzheimer's disease spans several decades, with a number of early genetic studies reporting an association between mutations in α~2~M and the risk of disease ([@r46][@r47][@r48]--[@r49]). This association has not, however, been confirmed by more recent genome-wide association studies (reviewed in ref. [@r50]), which suggests that additional factors such as posttranslational modification could be important. Interestingly, elevated levels in serum of α~2~M or PZP are reportedly associated with presymptomatic Alzheimer's disease in men and women, respectively ([@r51], [@r52]). Furthermore, both α~2~M and PZP are found to be colocalized with Aβ in the brain in Alzheimer's disease ([@r53], [@r54]). It is not yet known if the elevated levels of PZP measured in women with presymptomatic Alzheimer's disease are the consequence of a general innate immune system response, since PZP levels are reported to be elevated in several other inflammatory states including rheumatoid arthritis ([@r55]), Behçet's syndrome ([@r56]), psoriasis ([@r57], [@r58]), Chagas disease ([@r59]), and viral infection ([@r60], [@r61]). Nevertheless, the available data strongly suggest that both α~2~M and PZP are likely to participate in Aβ homeostasis in vivo. It remains to be determined whether or not their roles are overlapping or discrete.

Previous studies have reported that low levels of maternal plasma PZP are associated with spontaneous preterm birth ([@r62]) and an increased risk of preeclampsia ([@r63][@r64]--[@r65]). On the other hand, opposing and inconclusive data have also been reported regarding a negative correlation between maternal plasma PZP levels and preeclampsia ([@r66], [@r67]). As such, there is a need to reevaluate this association with greater consideration of both the clinical spectrum of preeclampsia ([@r68]) and the accurate quantification of PZP independent of the closely related α~2~M, which even modern proteomic methods have struggled to distinguish from each other ([@r67]). Although detailed analysis of the chaperone activity of PZP in pregnancy plasma in situ is outside of the scope of the current study, our results provide an indication that PZP deficiency could contribute to the accumulation of misfolded proteins in preeclampsia. Consistent with this idea, high levels of plasma PZP are associated with pregnancy-associated remission of rheumatoid arthritis ([@r69]), a condition exacerbated by the accumulation of damaged proteins in the synovial fluid of inflamed joints ([@r70], [@r71]). However, our inability to assay a large number of samples from individual women with preeclampsia and matched controls is a limitation of this study. Additionally, preeclampsia is a complex multifactorial syndrome, and previously reported immunomodulatory activities ([@r17], [@r72][@r73]--[@r74]) or currently undescribed functions of PZP that mirror the multifunctional nature of α~2~M could also be important (reviewed in ref. [@r75]).

It has previously been reported that microglia that are immunoreactive for PZP colocalize with Aβ deposits in the brain in Alzheimer's disease ([@r53]). The pathobiological relevance of PZP expression at sites of Aβ deposition, however, remains unclear. Given that our data demonstrate that PZP is found in extravillous trophoblasts in cell islands adjacent to placental Aβ plaques, there is a need to establish the relative contributions of fetal and maternal plasma PZP to normal placental function, including Aβ homeostasis. The observation that PZP is largely excluded from Aβ plaques in the placenta supports our hypothesis that PZP normally forms soluble complexes with Aβ that are subsequently taken up by cells and cleared. Codeposition of PZP with Aβ in the placenta in preeclampisa could indicate that the chaperone activity of PZP or receptors responsible for its clearance is overwhelmed or dysfunctional in the syndrome. The intriguing cytoplasmic and nuclear localization of PZP observed in the placenta suggests that this protein might also have currently undescribed intracellular roles ([*SI Appendix*, Fig. S4](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1817298116/-/DCSupplemental)). Using STRING analysis ([@r76]), nuclear importins 7 and 8 are predicted to bind to PZP with medium confidence, although further studies are needed to examine this possibility.

PZP Is Not a Major in Situ Inhibitor of Proteases in Pregnancy Plasma. {#s11}
----------------------------------------------------------------------

The emergence of the α~2~M tetramer from a dimeric precursor appears to have been driven by evolutionary pressures ([@r77]). However, it is clear that in many mammals, including humans, dimeric PZP has relevance in pregnancy- and in non--pregnancy-associated inflammatory states. Although α~2~M and PZP share extensive sequence identity, such identity does not occur in the protease bait region ([@r21]), which explains why the broad-spectrum protease inhibitory activity of α~2~M is not shared by PZP. Consistent with the results of several other in vitro studies, the results generated here using human pregnancy plasma in situ support the conclusion that α~2~M is much more proficient at trapping abundant endogenous plasma proteases compared with PZP ([@r23][@r24]--[@r25]). Given that protease trapping is currently the only biologically relevant mechanism known to expose the LRP1 binding site on PZP ([@r35]), it is plausible that this reaction occurs in vivo. If it does occur, however, the identities of the major protease substrates are currently unclear. Proteases from the fibrinolytic and coagulation cascade have been proposed as potential targets of PZP ([@r27]), but conflicting results have also been presented ([@r78]). When the protease specificity of the PZP bait region is analyzed using the bioinformatics tool PROSPER, cleavage sites are predicted for both metalloproteases matrixmetallopeptidase-2 and -9 and for serine proteases elastase-2 and cathepsin G ([@r79]). Limited in vitro data also suggest that metalloproteases and intracellular proteases, including elastase, might be endogenous substrates for PZP ([@r24], [@r26]). On the other hand, given that all of these proposed protease substrates are more efficiently trapped by the α~2~M tetramer than by the PZP dimer ([@r24], [@r26]), it is difficult to imagine that the up-regulation of PZP in pregnancy is exclusively linked to its protease-trapping function.

Pregnancy-Associated Maternal Adaptations Contribute to Proteostasis. {#s12}
---------------------------------------------------------------------

Research into the extracellular quality control of protein folding has primarily been driven by the knowledge that misfolded proteins accumulate in a large number of age-related disorders such as Alzheimer's disease, arthritis, atherosclerosis, and macular degeneration. The pregnancy-associated syndrome preeclampsia clearly stands apart from these conditions. On the other hand, mature age and pregnancy can both be viewed as life stages that involve chronically elevated physiological stresses that contribute to protein misfolding ([@r2], [@r14]). In addition to the accumulation of misfolded protein aggregates, there are numerous similarities between preeclampsia and many age-related protein-misfolding disorders, including strong inflammatory pathology and vascular dysfunction ([@r80], [@r81]). Furthermore, it has been shown that premature placental aging underlies early-onset preeclampsia ([@r82]), and it has been proposed that the placenta is a tractable model for aging human tissue ([@r83]). Interestingly, recent data suggest that, after preeclampsia, women have a fourfold increased risk of death from Alzheimer's disease than the general female population ([@r84]). While potentially explained by increased cardiovascular and cerebrovascular disease rates in this group, common pathophysiologies related to protein misfolding might also play a role. Therefore, it is tempting to speculate that a greater understanding of the maternal adaptations for controlling protein misfolding in pregnancy could help us to understand better the phenomenon of age-related protein misfolding and hence to contribute to the development of novel therapeutic strategies.

Materials and Methods {#s13}
=====================

All chemicals and buffer salts were obtained from Sigma-Aldrich, unless otherwise stated.

PZP and α~2~M Purification from Human Plasma. {#s14}
---------------------------------------------

Heparinized human pregnancy plasma was obtained from donors as approved by either the Cambridgeshire 2 Research Ethics Committee (reference no. 07/H0308/163) or the joint University of Wollongong (UOW) and Illawarra Shoalhaven Local Health District (ISLHD) Health and Medical Human Research Ethics Committee (application nos. 2013/377 and 2016/1016) and stored at ≤−20 °C until use. All participants provided written informed consent. Donated blood samples were deidentified before use in this study as specified in the relevant approved ethics applications. This included donations from women with no known pregnancy complication (control) and women diagnosed with preeclampsia. PZP was subsequently purified from control pregnancy plasma as described in ref. [@r33].

Native α~2~M was purified from normal (i.e., nonpregnant) blood plasma without amendment as described in ref. [@r85]. This collection was approved by the joint UOW and ISLHD Health and Medical Human Research Ethics Committee (application no. HE02/080). Transformed α~2~M was generated by incubating 1.4 µM native α~2~M with 400 mM NH~4~Cl in PBS (pH 7.4) overnight at room temperature, followed by extensive dialysis against PBS. Hypochlorite-modified α~2~M was generated by incubating 0.55 µM α~2~M with 120 µM NaOCl in PBS overnight at ambient room temperature, followed by extensive dialysis against PBS to remove unreacted NaOCl. Hypochlorite-modified α~2~M dimers were purified from residual α~2~M tetramer via Superose 6 10/300 GL size-exclusion chromatography (SEC).

Electrophoresis and Western Blot Analyses. {#s15}
------------------------------------------

Proteins were subjected to native gel electrophoresis using NuPAGE Novex 3 to 8% Tris-acetate gels and Novex Tris-glycine native buffers (Life Technologies). Denaturing gel electrophoresis was performed using NuPAGE Novex 4 to 12% Bis-Tris gels and NuPAGE Mes SDS running buffer. Where specified, samples were reduced by treatment with β-mercaptoethanol. Gels were stained using Instant Blue stain (Sigma-Aldrich). In experiments involving Hilyte-labeled Aβ~1--42~, the migration of the fluorescently labeled peptide was determined using a Typhoon Trio imager (GE Healthcare).

For Western blot analysis, proteins were subjected to electrophoresis as described above and transferred to nitrocellulose or polyvinylidene difluoride (PVDF) membrane. After blocking overnight at 4 °C in skim milk solution \[5% (wt/vol) skim milk powder in PBS\], the membranes were incubated with the relevant antibodies/streptavidin conjugates diluted in skim milk solution (1 h at 37 °C). Blots were imaged with an Amersham 600 imager (GE Healthcare) using enhanced chemiluminescence. PZP was detected using an affinity-purified polyclonal antibody (GeneTex), α~2~M was detected using monoclonal antibody 2N1/10 (Bio-Rad) or a polyclonal antibody (Dako), and Aβ~1--42~ was detected using monoclonal antibody W02 supernatant.

Thioflavin T Assays. {#s16}
--------------------

Aβ~1--42~ (5 µM; AnaSpec) was incubated at 32 °C with shaking in PBS containing ThT (25 µM) in the presence or absence of native α~2~M, PZP, or hypochlorite-modified α~2~M dimer (pretreated using NaOCl and purified from residual tetramers by SEC as described above). The ThT fluorescence of the samples was continuously monitored using a FLUOstar OPTIMA plate reader (BMG Labtech) with excitation and emission wavelengths of 440 and 480 nm (slit widths of 10 nm), respectively. At the conclusion of the assay, following brief centrifugation to pellet insoluble material (5 min at 21,000 × *g*), the relative amount of soluble Aβ~1--42~ in each sample was measured by subjecting 20 µL of the supernatant to native Western blot analysis and performing densitometry using ImageJ software (NIH). The density of soluble Aβ~1--42~ in samples containing dimeric αMs is presented relative to soluble Aβ~1--42~ in samples containing native tetrameric α~2~M.

4,4-Dianilino-1,1-Binaphthyl-5,5-Disulfonic Acid Assay. {#s17}
-------------------------------------------------------

For bisANS analyses, 170 nM native α~2~M tetramer, native PZP dimer, or hypochlorite-modified α~2~M dimer was incubated with 10 µM bisANS in PBS for 5 min at ambient room temperature before the fluorescence was measured on a FLUOstar OPTIMA plate reader with excitation and emission wavelengths of 360 and 490 nm (slit widths of ±10 nm), respectively. All reported values are corrected for the background fluorescence of bisANS in PBS.

Transmission Electron Microscopy. {#s18}
---------------------------------

Aβ~1--42~ was incubated in the presence or absence of native α~2~M, PZP, or oxidized α~2~M dimer as described for ThT assays. The samples were then applied to 400-mesh carbon film copper grids (Agar Scientific) and imaged on an FEI Tecnai G2 transmission electron microscope (CAIC; University of Cambridge). Images were analyzed using the SIS Megaview II Image Capture System (Olympus).

Biotin--Streptavidin Pull-Down Assays. {#s19}
--------------------------------------

Binding of PZP to commercially prepared biotinylated Aβ~1--42~ (bAβ~1--42~; Cambridge Bioscience) was performed following their coincubation at a 1:10 molar ratio of PZP to bAβ~1--42~ in PBS for 10 min at ambient room temperature. Biotin--streptavidin pull-down assays were performed using Dynabeads My One Streptavidin C1 according to the manufacturer's instructions (Life Technologies).

Turbidity Assays. {#s20}
-----------------

CS (1 µM in PBS; Sigma-Aldrich) was incubated in the presence or absence of native PZP or native α~2~M at 43 °C in a FLUOstar OPTIMA plate reader while the absorbance at 595 nm was continuously monitored. For clarity, kinetic curves and analysis of end-point absorbance values are presented in separate charts. In other experiments, CPK (5 µM in PBS; Sigma-Aldrich) was incubated in the presence or absence of ECAM, PZP, or α~2~M at 55 °C while the absorbance at 595 nm was continuously monitored as described above. Recombinant ECAM was purified as described in ref. [@r86]. The plasmid used for purifying ECAM was a gift from Andréa Dessen, Structural Biology Institute (IBS), Grenoble, France.

Using methods similar to previous studies, we assessed the aggregation of protein in human plasma in situ ([@r37], [@r38]). Briefly, heparinized blood plasma samples from individuals exhibiting uncomplicated pregnancy (*n* = 6) or preeclampsia (*n* = 9) were pooled. Total protein was estimated using the bicinchoninic acid assay, and the plasma was supplemented with 0.01% NaN~3~ to prevent microbial growth during the assay. PZP quantification was performed using an R&D Systems ELISA kit according to the manufacturer's instructions (In Vitro Technologies). Four 70-µL aliquots of pooled plasma from each cohort were dispensed into a Griener 384-well plate and incubated at 38 °C for 500 h with periodic agitation in a FLUOstar OPTIMA plate reader (BMG Labtech). The absorbance at 595 nm was measured as an indicator of plasma turbidity.

Protease-Trapping Assays. {#s21}
-------------------------

The protease-trapping activity of purified PZP was examined after incubation with chymotrypsin at a 2:1 molar ratio of PZP to chymotrypsin for 30 min at 37 °C by subjecting the proteins to separation using native gel electrophoresis. Under these conditions, protease trapping is detected by the formation of a high-molecular-mass complex consisting of two molecules of PZP and one molecule of protease ([@r23]). To examine the ability of PZP to trap proteases in heparinized human pregnancy plasma in situ, plasma was incubated at 37 °C for 45 min in the presence or absence of 1 µM chymotrypsin. An additional sample (not supplemented with chymotrypsin) was held on ice to limit the activity of endogenous plasma protease. Following separation using 3 to 8% Tris-acetate gels, proteins were transferred to PVDF membranes and probed for PZP or α~2~M (as described in [*Electrophoresis and Western Blot Analyses*](#s15){ref-type="sec"}).

Placental Immunohistochemistry and Immunofluorescence. {#s22}
------------------------------------------------------

We analyzed placental tissues of women with medically indicated delivery in the context of early-onset severe preeclampsia \[*n* = 11; gestational age (GA) at delivery (mean ± SD): 30 ± 3 wk\]. Tissues from a group of women with spontaneous idiopathic preterm birth at a similar gestational age (*n* = 8; GA: 30 ± 2, *P* = 0.453) served as the best possible control. All women delivered at Yale-New Haven Hospital and provided signed informed consent under protocols approved by the Human Investigation Committee of Yale University. Donated tissues were deidentified before use in this study as specified in the relevant approved ethics application. Within minutes of the time of delivery of the placenta, a full-thickness biopsy was retrieved from the central portion of the placenta and fixed in formalin and embedded in paraffin. Five-micrometer serial sections were deparaffinized in xylene and rehydrated with graded ethanol to potassium PBS solution (pH 7.2). Following antigen retrieval with citrate buffer, sections were pretreated with 1% hydrogen peroxide for 15 min followed by incubation for 1 h at room temperature with 5% donkey serum (Jackson ImmunoResearch Laboratories). Sections were then incubated overnight at 4 °C with primary antibodies followed by incubation for 1 h at room temperature with biotinylated donkey anti-rabbit or anti-mouse IgG (1:600; Jackson ImmunoResearch Laboratories) as appropriate. Signal amplification and detection were performed with avidin--biotin (VECTASTAIN Elite ABC; Vector Laboratories) using Vector NovaRed as peroxidase substrate. Sections exposed to nonimmune IgG served as negative control. The following primary antibodies were used: polyclonal anti-PZP (1:100; GeneTex), monoclonal anti-Aβ antibodies (clone W0-2; Millipore), monoclonal anti--cytokeratin-7 (1:100; Invitrogen), and monoclonal anti--HLA-G (1:100; clone 4H80; Abcam).

To colocalize PZP with Aβ, we performed double immunofluorescence on select tissues. After deparaffinization and antigen retrieval with citrate buffer, the slides were blocked with 100 mM glycine followed by 10% goat serum for 1 h at room temperature. Slides were further incubated overnight at 4 °C with the mixture of primary antibodies anti-PZP (1:100) and anti-Abeta (clone W02; 1:250). Following washing, slides were exposed for 1 h at room temperature to a secondary antibody mixture containing 2 µg/mL goat anti-mouse IgG conjugated to Alexa Fluor 488 and 2 µg/mL goat anti-rabbit IgG conjugated to Alexa Fluor 594 plus 1 µg/mL DAPI. Slides were mounted with ProLong Gold Antifade medium and images were captured using a Zeiss LSM 700 confocal laser-scanning microscope.
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